|
|
Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study.
Raouf Ben Abdelali
,
Vahid Asnafi
,
Thibaut Leguay
,
Nicolas Boissel
,
Agnès Buzyn
et al.
Journal articles
hal-00777203v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study
Arsène Mekinian
,
Eric Grignano
,
Thorsten Braun
,
Olivier Decaux
,
Eric Liozon
et al.
Journal articles
hal-01299293v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Phase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma: the Intergroupe Francophone du Myelome 2009-01 trial
P. Rodon
,
C. Hulin
,
B. Pegourie
,
M. Tiab
,
B. Anglaret
et al.
Journal articles
hal-01116536v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Addition of lomustine to idarubicin and cytarabine improves the outcome of elderly patients with de novo acute myeloid leukemia: a report from the GOELAMS.
Arnaud Pigneux
,
Jean-Luc Harousseau
,
Francis Witz
,
Mathieu Sauvezie
,
Marie-Christine Bene
et al.
Journal articles
hal-00849638v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma
Maroulio Pertesi
,
Maxime Vallée
,
Xiaomu Wei
,
Maria Revuelta
,
Perrine Galia
et al.
Journal articles
hal-02190723v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL group
Thorsten Braun
,
Sophie Cereja
,
Sylvie Chevret
,
Emmanuel Raffoux
,
Marie Beaumont
et al.
Journal articles
hal-01237097v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Evaluation of the (R)VAD+C regimen for the treatment of newly diagnosed mantle cell lymphoma. Combined results of two prospective phase II trials from the French GOELAMS group.
Rémy Gressin
,
Sylvie Caulet-Maugendre
,
Eric Deconinck
,
Olivier Tournilhac
,
Emmanuel Gyan
et al.
Journal articles
inserm-00508037v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Front-line high-dose chemotherapy with rituximab showed excellent long-term survival in adults with aggressive large b-cell lymphoma: final results of a Phase II GOELAMS Study.
Marie-Sarah Dilhuydy
,
Thierry Lamy
,
Charles Foussard
,
Remy Gressin
,
Philippe Casassus
et al.
Journal articles
inserm-00508035v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Results of a Prospective Study of High-Dose or Conventional Anthracycline-Cyclophosphamide Regimen Plus Radiotherapy for Localized Adult Non-Hodgkin's Primary Bone Lymphoma
A Schmidt-Tanguy
,
R Houot
,
S Lissandre
,
J.F. Abgrall
,
P Casassus
et al.
Journal articles
hal-01155268v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Early matched sibling hematopoietic cell transplantation for adult AML in first remission using an age-adapted strategy: long-term results of a prospective GOELAMS study.
Bruno Lioure
,
Marie C Béné
,
Arnaud Pigneux
,
Anne Huynh
,
Patrice Chevallier
et al.
Journal articles
hal-00849702v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 study.
Mathilde Hunault-Berger
,
Thibaut Leguay
,
Xavier Thomas
,
Ollivier Legrand
,
Françoise Huguet
et al.
Journal articles
hal-00821138v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Efficacy of Azacitidine (AZA) in Autoimmune and Inflammatory Disorders (AID) Associated with Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
Jean-Baptiste Fraison
,
Arsène Mekinian
,
Eric Grignano
,
Jean-Emmanuel Kahn
,
Jean-Benoît Arlet
et al.
Blood, 2015, 126 (23), pp.1695
Journal articles
hal-01300814v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|